(Q47341597)

14 January 2018

title

Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study (English)

1 reference

14 January 2018

1 reference

6

Enrico Ferrazzi

1 reference

14 January 2018

author name string

Valentina Conserva

1

1 reference

14 January 2018

Marialuisa Muggiasca

2

1 reference

14 January 2018

Luisa Arrigoni

3

1 reference

14 January 2018

Valeria Mantegazza

4

1 reference

14 January 2018

Edoardo Rossi

5

1 reference

14 January 2018

language of work or name

1 reference

3 April 2012

1 reference

14 January 2018

Journal of Maternal-Fetal and Neonatal Medicine

published in

1 reference

14 January 2018

volume

25

1 reference

14 January 2018

issue

8

1 reference

14 January 2018

page(s)

1467-1473

1 reference

14 January 2018

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

NK cells and human pregnancy--an inflammatory view.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Inherited thrombophilias and adverse pregnancy outcome: screening and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Inherited thrombophilia and pregnancy complications revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Mutations in coagulation factors in women with unexplained late fetal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Thrombophilic disorders and fetal loss: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Comparison of fetal and neonatal growth curves in detecting growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Fitting growth curves to head and abdomen measurements of the fetus: a multicentric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Recurrence of ischemic placental disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Subsequent pregnancy outcome in women with a history of preeclampsia and/or HELLP syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Recurring complications in second pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Heparin and maternal fetal interface: why should it work to prevent pregnancy complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Obstetric outcomes subsequent to intrauterine death in the first pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14767058.2011.643326

10.3109/14767058.2011.643326

21 January 2018

Identifiers

DOI

1 reference

14 January 2018

1 reference

14 January 2018